About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Massachusetts | 399 Studies

Clinical Trials Colorectal CancerMassachusetts

Colorectal Cancer Clinical Trials in Massachusetts

Find 399 clinical trials for colorectal cancer near Massachusetts. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 399 trials

CompletedTrial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.This study compares in the first study period combination of Irinotecan with three different methods of administration by Fluoropyrimidine. (ie. infusion, bolus and oral).NCT00101686·Birmgingham, Alabama and 174 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedMulti-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesThe objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer.NCT01260168·Birmingham, Alabama and 20 others

TerminatedCombination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or…NCT00023868·Tucson, Arizona and 8 others

RecruitingStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer…NCT05489211·Los Angeles, California and 95 others

UnknownStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesStudy of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337·Los Angeles, California and 26 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

TerminatedA Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal CancerThe purpose of this study is to evaluate relatlimab in combination with nivolumab, administered as a fixed-dose combination (nivolumab-relatlimab FDC, also referred to as…NCT05328908·Springdale, Arkansas and 138 others

CompletedS0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049335·Mobile, Alabama and 89 others

CompletedTrastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal CancerThis study will evaluate the efficacy, safety, and pharmacokinetics of Trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor 2 (HER2)-overexpressing…NCT04744831·Chicago, Illinois and 62 others

RecruitingFeasibility of the LUM Imaging System for Detection of Gastrointestinal CancersThe overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers…NCT02584244·Boston, Massachusetts

RecruitingA Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesThe goal of this clinical trial is to learn if KQB365 works to treat advanced solid tumor cancer in adults. It will also learn about the safety of KQB365.NCT06720987·Phoenix, Arizona and 10 others

CompletedPaired Promotion of Colorectal Cancer and Social Determinants of Health ScreeningThis work is an implementation science study that examines different aspects of implementing a single intervention.NCT04585919·Boston, Massachusetts and 3 others

UnknownColon Cancer Risk-stratification Via Optical Analysis of Rectal UltrastructureThis is a study whose focus is on understanding the clinical utility of rectal ultrastructure in detecting colonic neoplasm.NCT02730702·Boston, Massachusetts

CompletedA Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies.NCT05039177·Birmingham, Alabama and 13 others

Active not recruitingPlatform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationThis is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ443 with select therapies in patients with advanced solid tumors harboring the KRAS G12C mutation.NCT05358249·Boston, Massachusetts and 12 others

RecruitingDistance-Based Exercise to Preserve Function and Prevent DisabilityThis clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to…NCT07059884·Dublin, California and 17 others

TerminatedEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaThe primary objective of this study is to compare the additive efficacy of SIM versus placebo in combination with leucovorin (folinic acid), irinotecan, and fluorouracil (FOLFIRI)…NCT01479465·Huntsville, Alabama and 108 others

CompletedAn Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has SpreadThis purpose of this study is to evaluate nivolumab (BMS-936558) in combination with standard of care (SOC) chemotherapy with bevacizumab for the treatment of first-line…NCT03414983·Birmingham, Alabama and 48 others

CompletedPopulation-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health ITAlthough there is considerable evidence that current health IT can improve certain elements of care, the most effective and efficient implementation of health IT systems for…NCT01372527·Boston, Massachusetts

Active not recruitingThe Northern-European Initiative on Colorectal CancerColorectal cancer (CRC) is a major burden in western countries. The disease develops from precursor lesions during a long time-interval.NCT00883792·Boston, Massachusetts and 6 others

PreviousPage 11 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma